Ma Yan, Lu Zhenqi, Qiu Jiajia, Luo Huiyu, Tang Lichen, Li Yun, Li Ping
Department of Nursing, Fudan University Shanghai Cancer Center, Shanghai, China.
Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Asia Pac J Oncol Nurs. 2023 Dec 22;11(2):100364. doi: 10.1016/j.apjon.2023.100364. eCollection 2024 Feb.
The purpose of this study was to systematically integrate the experience of symptoms of breast cancer patients receiving endocrine therapy, analyze the patients' understanding and coping status of symptoms, and provide information for the development of targeted symptom management measures.
We searched databases including PubMed/MEDLINE, MEDLINE (Ovid), Web of Science, EMBASE (Ovid), CINAHL (EBSCO), and ProQuest from inception to September 25, 2023. Literature was screened and analyzed using Endnote software, evaluated using the Joanna Briggs Institute Critical Appraisal Tool for Qualitative Research, and the results were integrated using JBI's Pooled Integration Methodology.
Three composite findings were derived from 10 studies: symptom distress during endocrine therapy; coping in symptom experience; and support needs.
Emphasis should be placed on the symptomatic experience of breast cancer patients undergoing endocrine therapy, and effective interventions should be developed to improve patients' medication compliance and quality of life. Finally, the long-term survival rate of patients is improved.
CRD42023466073.
本研究旨在系统整合接受内分泌治疗的乳腺癌患者的症状体验,分析患者对症状的认知和应对状况,为制定针对性的症状管理措施提供信息。
我们检索了包括PubMed/MEDLINE、MEDLINE(Ovid)、Web of Science、EMBASE(Ovid)、CINAHL(EBSCO)和ProQuest在内的数据库,检索时间跨度从建库至2023年9月25日。使用Endnote软件对文献进行筛选和分析,采用乔安娜·布里格斯研究所定性研究批判性评价工具进行评估,并运用JBI的汇总整合方法整合结果。
从10项研究中得出了三项综合结果:内分泌治疗期间的症状困扰;症状体验中的应对方式;以及支持需求。
应重视接受内分泌治疗的乳腺癌患者的症状体验,制定有效的干预措施以提高患者的用药依从性和生活质量。最终提高患者的长期生存率。
CRD42023466073。